Lincoln Alternative Strategies LLC - 18 Sep 2025 SCHEDULE 13G/A Report for Calidi Biotherapeutics, Inc. Common stock, par value $0.0001 per share (CLDI)

Filing Manager
Lincoln Alternative Strategies LLC
Reporting Manager
Lincoln Alternative Strategies LLC
Security
Calidi Biotherapeutics, Inc. Common stock, par value $0.0001 per share
Symbol
CLDI
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
10 Feb 2026, 14:08:21 UTC
Date of event
18 Sep 2025
Previous filing
27 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Lincoln Alternative Strategies LLC disclosed 0% ownership in Calidi Biotherapeutics, Inc. Common stock, par value $0.0001 per share (CLDI) on 18 Sep 2025."

Quick Takeaways

  • Lincoln Alternative Strategies LLC filed SCHEDULE 13G/A for Calidi Biotherapeutics, Inc. Common stock, par value $0.0001 per share (CLDI).
  • Disclosed ownership: 0%.
  • Date of event: 18 Sep 2025.

What Changed

  • Previous schedule filing date: 27 Aug 2025.
  • Current filing was accepted on 10 Feb 2026, 14:08.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lincoln Alternative Strategies LLC 0% 0 0 0 /s/ Stephen Temes Stephen Temes/Managing Member

Sponsored